SG Americas Securities’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
SG Americas Securities's UPB Position: Q2 2026 in Review
SG Americas Securities opened a new position in Upstream Bio (UPB) in Q2 2026: 20,338 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #2957 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in UPB as recently as Q4 2025.
SG Americas Securities first reported a position in UPB in Q4 2024 and has held it in 3 quarters since. The position peaked at $150K in Q4 2025. 148 funds tracked by Wall St. Rank hold UPB as of Q2 2026.
- SG Americas Securities held 20,338 shares of Upstream Bio worth $141K as of Q2 2026.
- Upstream Bio was a new SG Americas Securities position in Q2 2026.
- Upstream Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2957 holding.
- SG Americas Securities first reported a position in Upstream Bio in Q4 2024 and has held it in 3 quarters since.
- SG Americas Securities's Upstream Bio position peaked at $150K in Q4 2025.
- 148 funds tracked by Wall St. Rank held Upstream Bio as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.